These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3745476)

  • 1. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain differences in the opsonisation of Staphylococcus epidermidis.
    Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
    Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic requirements of Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates.
    Lamari F; Anastassiou ED; Stamokosta E; Photopoulos S; Xanthou M; Dimitracopoulos G; Karamanos NK
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):363-74. PubMed ID: 10933528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonic defense to Staphylococcus epidermidis in the premature neonate.
    Fleer A; Gerards LJ; Aerts P; Westerdaal NA; Senders RC; van Dijk H; Verhoef J
    J Infect Dis; 1985 Nov; 152(5):930-7. PubMed ID: 4045255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic activity in serum from septic infants treated with intravenous immunoglobulin.
    Maródi L; Kalmár A; Szabó I
    Arch Dis Child; 1989 Apr; 64(4):530-4. PubMed ID: 2751327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dialysate fluids on phagocytosis and killing by normal neutrophils.
    Harvey DM; Sheppard KJ; Morgan AG; Fletcher J
    J Clin Microbiol; 1987 Aug; 25(8):1424-7. PubMed ID: 3624441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence.
    Gordon DL; Avery VM; Rice JL; McDonald PJ
    FEMS Microbiol Immunol; 1989 Dec; 1(8-9):417-23. PubMed ID: 2697319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis.
    Verbrugh HA; Keane WF; Hoidal JR; Freiberg MR; Elliott GR; Peterson PK
    J Infect Dis; 1983 Jun; 147(6):1018-29. PubMed ID: 6854062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
    van Bronswijk H; Verbrugh HA; Heezius HC; Renders NH; Fleer A; van der Meulen J; Oe PL; Verhoef J
    Immunology; 1989 May; 67(1):81-6. PubMed ID: 2737697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.